Patents by Inventor Ingrid Bolin

Ingrid Bolin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bacterial antigens and vaccine compositions
    Publication number: 20020168726
    Abstract: The present invention relates to recombinant polypeptides which constitute Helicobacter pylori surface-exposed antigens with an approximate molecular weight of 29 kDa. The invention furthermore provides nucleic acid molecules coding for the said polypeptides, as well as vectors and host cells comprising such nucleic acid molecules. The said recombinant polypeptides are useful for the diagnosis of H. pylori infections and for the manufacture of vaccine compositions which will elicit a protective immune response against such infections, said vaccine compositions being suitable for both therapeutic and prophylactic use.
    Type: Application
    Filed: September 15, 1999
    Publication date: November 14, 2002
    Inventors: Ingrid Bolin, Ann-Mari Svennerholm
  • VACCINE COMPOSITION COMPRISING HELICOBACTER PYLORI FLAGELLIN POLYPEPTIDE
    Publication number: 20020028210
    Abstract: The present invention relates to a vaccine composition for inducing a protective immune response to Helicobacter pylori infection, said composition comprising an immunogenically effective amount of a polypeptide comprising at least one Helicobacter pylori flagellin polypeptide, optionally together with a pharmaceutically acceptable carrier or diluent.
    Type: Application
    Filed: December 3, 1997
    Publication date: March 7, 2002
    Inventors: THOMAS BERGLINDH, INGRID BOLIN, BJORN MELLGARD, ANN-MARI SVENNERHOLM
  • Bacterial antigens and vaccine compositions
    Patent number: 6025164
    Abstract: The present invention relates to recombinant polypeptides which constitute Helicobacter pylori surface-exposed antigens with an approximate molecular weight of 29 kDa. The invention furthermore provides nucleic acid molecules coding for the said polypeptides, as well as vectors and host cells comprising such nucleic acid molecules. The said recombinant polypeptides are useful for the diagnosis of H. pylori infections and for the manufacture of vaccine compositions which will elicit a protective immune response against such infections, said vaccine compositions being suitable for both therapeutic and prophylactic use.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: February 15, 2000
    Assignee: Astra Aktiebolag
    Inventors: Ingrid Bolin, Ann-Mari Svennerholm